HER2 humanized monoclonal antibody: Began a Phase II trial

Genentech Inc. (GNE), South San Francisco Product: HER2 humanized monoclonal antibody Indication: Metastatic breast cancer resistant to standard therapy Status: Began a Phase II trial ...